Mini-Networking Night: Careers in the Public & Non-Profit Sector
Date/TimeDate - 23/10/2019
6:15 pm - 8:00 pm
LocationPrenup Pub, 191 College Street, Toronto,
Mini-Networking Night: Careers in the Public & Non-Profit Sector
Mini-Networking Night focused on careers in the public and non-profit sector will feature guests from Ontario Genomics, University Health Network, Cancer Care Ontario, Ontario Institute for Cancer Research, Canadian Cancer Society, and the Ministry of Health on October 23rd, 2019. Interested in learning more about this career path, join us for an exciting networking night where some of the most prominent leaders in the field in Toronto will talk about their path to success!
Date: Wednesday, October 23rd, 2019
Registration: Opens on October 7th, 2019
Time: 6:15 – 8:00 pm
Location: Prenup Pub (191 College St., ), Second Floor.
Very limited space available. Registered individuals who do not show up will be prevented from registering for future events.
The Mini-Networking Series is $10 for all students, post-docs and other research trainees at the University of Toronto or the affiliated research institutions, to help cover the cost of food. External participants must pay a $15 fee to register.
Guests for this event:
Michelle Lloyd, PhD – Director, Quality Management & QMP – Cancer Care Ontario
Carlos Zepeda-Velázquez, PhD – Research Scientist – Ontario Institute for Cancer Research
Robert Chen, PhD – Research Impact Specialist – University Health Network
Ann Meyer, PhD – Advisor, Sector Innovation and Programs – Ontario Genomics
Betty Zou, PhD – Manager, Research Communications – Canadian Cancer Society
Andrew Levy, PhD – Senior Program Consultant – Ministry of Health
***Note: Ticket for U of T students and trainees are available for $10 to logged in users.***
Michelle Lloyd, PhD
Michelle Lloyd is the Director of Quality Management for the provincial cancer screening programs at Cancer Care Ontario (CCO). She oversees the cancer screening evaluation, analytics and quality improvement teams. Prior to joining CCO, Michelle was the Senior Manager, Performance Improvement at the Centre for Addictions and Mental Health (CAMH), overseeing the implementation of Health Quality Ontario’s (HQO) Mental Health Quality Standards. Michelle was the Associate Director of Evidence and Guideline Development at the Registered Nurses’ Association of Ontario (RNAO) where she oversaw the research and evidence development teams and the methodology for guideline development. She also led the development of RNAO’s patient and family advisory council. Michelle was Interim Manager of the Cancer Quality Council of Ontario where she led the national review of cancer drug funding sustainability. Michelle was Research Director at the Ivey International Centre for Health Innovation at Western University where was responsible for overseeing the development of the research strategy and execution of the organization’s key health innovation research projects. Michelle was also the Director, Performance Measurement & Reporting in the Health System Performance branch of HQO where she lead the development of online reporting tools for long-term care, home care, and patient safety, and the Ontario Primary Care Performance Measurement Initiative. Michelle has a PhD in Medical Genetics from the University of Toronto, and Master and Bachelor of Science degrees in Biochemistry from Queens University.
Carlos Zepeda-Velázquez, PhD
Dr. Zepeda-Velázquez earned his B.Sc. degree in Pharmaceutical Chemistry from La Salle University and his M.Sc. in Organic Chemistry from National Autonomous University of Mexico in 2003 and 2006 respectively. Subsequently, he worked as a process chemist at Signa, S.A de C.V. (Apotex Pharmachem INC). For his doctoral studies, he moved to Canada in 2009 and joined the group of Dr. McNulty at McMaster University where he completed the total synthesis of the anticancer natural product (+)-trans-Dihydrolycoricidine. He then moved to the Ontario Institute for Cancer Research with Dr. Rima Al-awar, working on novel anti-tumor agents and in 2016 he was promoted to Research Scientist. His research focuses on the chemical biology of chromatin regulation and drug discovery.
Robert Chen, PhD
Robert is a Research Impact Specialist at the University Health Network where he measures and advises on research performance metrics. His current work stemmed from his internship in 2018 at the Ontario Brain Institute where he did similar work on a different scale. Prior to that, Robert did his PhD and a short postdoctoral fellowship at the Krembil Research Institute under the supervision of Dr. Elise Stanley, and his MSc at the Tanz Centre for Research in Neurodegenerative Diseases under the joint supervision of Dr. Anurag Tandon and Dr. Howard Mount.
Ann Meyer, PhD
Ann supports the implementation of strategic initiatives aimed at bringing new genomic-derived solutions to Ontario’s key sectors. Ann helps build effective relationships by connecting, enabling and working with leading academics and diverse partners and partner organizations to advance collaborative investment opportunities, and she is the main point of contact for several funded projects.
Prior to joining Ontario Genomics, Ann was the Manager, Knowledge and Research Exchange at the Ontario Institute for Cancer Research. During her graduate studies at the University of Guelph, Ann took part in the Hub Incubator program and co-founded BioDatAlign Inc.
Ann has a PhD in Plant Agriculture, Crop Breeding and Genetics and a BSc Honours in Biological Science from the University of Guelph. She held a postdoctoral fellowship in the Department of Pathobiology at the University of Guelph.
Betty Zou, PhD
Betty Zou is the manager, research communications at the Canadian Cancer Society (CCS) where she works to enhance the profile of CCS by promoting its research activities. Prior to this position, she was a communications officer at Sunnybrook Research Institute. Betty completed her PhD in the Department of Molecular Genetics at the University of Toronto and her BSc at Western University.
Andrew Levy, PhD
Andrew is a seasoned health care leader with experiences in the private and public sectors. Currently he is a digital health strategist in the Ministry of Health’s Digital Health Program Branch. Prior to joining the ministry, Andrew was the Director of Health Informatics and Analytics at Self Care Catalysts a digital health company based in Toronto focused on the collection of Real World Evidence. Andrew has a passion for using digital health and data to solve complex health care problems.